The treatment of cutaneous T-cell lymphoma with photopheresis.
about
Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loadingCutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and managementT-cell lymphomas, a challenging disease: types, treatments, and future.Plasmonic nanoparticle-generated photothermal bubbles and their biomedical applications.Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.LANTCET: elimination of solid tumor cells with photothermal bubbles generated around clusters of gold nanoparticles.The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indicationsGuidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Treatment of mycosis fungoides: overview.Guidelines on the use of extracorporeal photopheresisThe effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.Rationales for therapeutic apheresis.Determination of xanthotoxin using a liquid chromatography-mass spectrometry and its application to pharmacokinetics and tissue distribution model in rat.Irradiation therapy: from UV light to electron beam.Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma.Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinionPhototherapy of mycosis fungoides.Extracorporeal photopheresis: how, when, and why.Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.Pruritus in cutaneous T-cell lymphoma: a review.Cutaneous T-cell lymphomas: a review of new discoveries and treatments.Photopheresis (extracorporeal photochemotherapy).Cutaneous T cell lymphoma: update on treatment.Romidepsin: a histone deacetylase inhibitor for refractory cutaneous T-cell lymphoma.Extracorporeal photopheresis: technique, established and novel indications.Therapeutic apheresis for patients with cancer.Properties and reactivity of nucleic acids relevant to epigenomics, transcriptomics, and therapeutics.Erythrodermic mycosis fungoides and Sézary syndrome treated with extracorporeal photopheresis as part of a multimodality regimen: A single-centre experience.Drug-drug interaction after single oral doses of the furanocoumarin methoxsalen and cyclosporine.Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management.Extracorporeal photopheresis for the treatment of early-stage mycosis fungoides.Extracorporeal Photopheresis-An Overview
P2860
Q24815134-2AC26DB6-1005-4500-B2C3-B059D4B12D95Q27024076-818DC16C-A5B7-4471-B361-CC03E5F36991Q30244553-3F33A136-4558-4254-A283-C17676BF5E1EQ30480282-C9BA0298-769A-419E-8AD9-F4864E7629B1Q30650570-72DAE8C7-5B28-4E7E-9509-BBAD68E39B0DQ33371962-F39445CD-6137-4CD5-829E-9D8D178B5769Q33746059-CF775B88-CDF0-4AF2-8F01-8CD254DA23B6Q34122035-76DEBCF7-87E3-47B0-A20A-EE373F2625F1Q34574172-5634B0F9-94E3-4065-97B4-EFDDF162F763Q34918643-4B761A0A-1746-4F2A-A2A4-BD097BD63213Q35858578-2F7D1DF0-1D7A-4BE6-89F8-64C1D82420EEQ36270085-8A20A2BA-B6AF-4512-B349-00CCF6CB26EBQ36317448-0FBCBE82-6BB5-4164-916C-F5AF2197C760Q36367919-8666ABBE-59C5-4B17-A7CB-DDE8919B49EAQ36470196-7B7B25D3-724A-4DA5-9A7E-74D7BD4D4FF6Q36930962-F1379081-C2D2-4990-BB93-19910D398C8DQ37154179-2B6CDE2D-1CC7-4147-A838-DDEDAB5F38FDQ37851562-BF54AF2F-8013-43DC-A644-744954719561Q37928578-BEDEF931-67AC-4DDA-ABD2-AEC422F25EB6Q37944565-4037AD7E-9818-4D88-B252-1BB8652AF43EQ37979593-A3FF920F-0F3E-4354-ABC6-866A0373C782Q37981969-1739220B-9094-46D1-BB99-154DBEF35256Q38031780-16765544-2DAF-4193-9311-006D4DFF84B1Q38036396-7198014E-D246-484A-A96E-F4AE85690001Q38042561-0631B42F-ED07-4D3E-9FAD-3768D275D969Q38211775-7EC013BC-1910-47A3-A0CF-8E97A4F04721Q38287610-0D62BE82-EEBF-42BD-9EAD-32C5A9ABCE43Q38780402-CB4D1A31-CF61-4F5C-AD5E-68C035E96B12Q40615391-B2C6EF8A-0588-4878-9CF7-62EE9951CB92Q46575523-DB5B21AF-BA67-466C-B46A-17472D70C5FDQ48034709-B5FF0CAF-F4B2-457B-B0E4-06750DE83959Q48365579-4F1AB466-E4D9-46C4-9EEB-A5798B7938D9Q57167371-909000CA-E335-449F-85AB-5B8F01B06F00
P2860
The treatment of cutaneous T-cell lymphoma with photopheresis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The treatment of cutaneous T-cell lymphoma with photopheresis.
@ast
The treatment of cutaneous T-cell lymphoma with photopheresis.
@en
type
label
The treatment of cutaneous T-cell lymphoma with photopheresis.
@ast
The treatment of cutaneous T-cell lymphoma with photopheresis.
@en
prefLabel
The treatment of cutaneous T-cell lymphoma with photopheresis.
@ast
The treatment of cutaneous T-cell lymphoma with photopheresis.
@en
P2860
P1433
P1476
The treatment of cutaneous T-cell lymphoma with photopheresis.
@en
P2093
John A Zic
P2860
P304
P356
10.1111/J.1396-0296.2003.01646.X
P577
2003-01-01T00:00:00Z